Tags

Type your tag names separated by a space and hit enter

[Personalized approach for direct oral anticoagulant prescription: from theory to practice].
Ter Arkh. 2019 Jul 15; 91(7):111-120.TA

Abstract

Data on possibilities of personalized approach for direct oral anticoagulants (DOAC) choice in patients with atrial fibrillation are presented in the article. We also review clinical and fundamental studies and future perspectives on pharmacogenetic and pharmacokinetic tests to predict the efficacy and safety of DOAC.

Authors+Show Affiliations

Sechenov First Moscow State Medical University (Sechenov University).Sechenov First Moscow State Medical University (Sechenov University).Sechenov First Moscow State Medical University (Sechenov University).Sechenov First Moscow State Medical University (Sechenov University).Sechenov First Moscow State Medical University (Sechenov University).Sechenov First Moscow State Medical University (Sechenov University).

Pub Type(s)

Journal Article
Review

Language

rus

PubMed ID

32598744

Citation

Skripka, A I., et al. "[Personalized Approach for Direct Oral Anticoagulant Prescription: From Theory to Practice]." Terapevticheskii Arkhiv, vol. 91, no. 7, 2019, pp. 111-120.
Skripka AI, Kogay VV, Listratov AI, et al. [Personalized approach for direct oral anticoagulant prescription: from theory to practice]. Ter Arkh. 2019;91(7):111-120.
Skripka, A. I., Kogay, V. V., Listratov, A. I., Sokolova, A. A., Napalkov, D. A., & Fomin, V. V. (2019). [Personalized approach for direct oral anticoagulant prescription: from theory to practice]. Terapevticheskii Arkhiv, 91(7), 111-120. https://doi.org/10.26442/00403660.2019.07.000045
Skripka AI, et al. [Personalized Approach for Direct Oral Anticoagulant Prescription: From Theory to Practice]. Ter Arkh. 2019 Jul 15;91(7):111-120. PubMed PMID: 32598744.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Personalized approach for direct oral anticoagulant prescription: from theory to practice]. AU - Skripka,A I, AU - Kogay,V V, AU - Listratov,A I, AU - Sokolova,A A, AU - Napalkov,D A, AU - Fomin,V V, Y1 - 2019/07/15/ PY - 2020/04/16/received PY - 2020/6/30/entrez PY - 2020/7/1/pubmed PY - 2020/7/17/medline KW - apixaban KW - dabigatran KW - direct oral anticoagulants KW - edoxaban KW - personalized approach KW - pharmacogenetics KW - pharmacokinetics KW - rivaroxaban SP - 111 EP - 120 JF - Terapevticheskii arkhiv JO - Ter. Arkh. VL - 91 IS - 7 N2 - Data on possibilities of personalized approach for direct oral anticoagulants (DOAC) choice in patients with atrial fibrillation are presented in the article. We also review clinical and fundamental studies and future perspectives on pharmacogenetic and pharmacokinetic tests to predict the efficacy and safety of DOAC. SN - 0040-3660 UR - https://www.unboundmedicine.com/medline/citation/32598744/[Personalized_approach_for_direct_oral_anticoagulant_prescription:_from_theory_to_practice] L2 - https://medlineplus.gov/bloodthinners.html DB - PRIME DP - Unbound Medicine ER -